DE3410641A1 - Vitamin-containing skin protective composition - Google Patents
Vitamin-containing skin protective compositionInfo
- Publication number
- DE3410641A1 DE3410641A1 DE19843410641 DE3410641A DE3410641A1 DE 3410641 A1 DE3410641 A1 DE 3410641A1 DE 19843410641 DE19843410641 DE 19843410641 DE 3410641 A DE3410641 A DE 3410641A DE 3410641 A1 DE3410641 A1 DE 3410641A1
- Authority
- DE
- Germany
- Prior art keywords
- skin
- vitamin
- agent according
- allergies
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Es ist bekannt, daß nach der Einnahme von oralem Vitamin E eineIt is known that after taking oral vitamin E, a
Anreicherung in der Haut stattfindet.Accumulation takes place in the skin.
Shiratori Life. Sci. 14, 929 (1974) Diese Anreicherung in der Haut bringt zahlreiche Vorteile, die überraschend und bisher nicht bekannt waren: 1) Schutz der Haut vor Allergien, insbesondere Sonnenallergien und Schutz vor UV-Strahlen 2) Bei Pigmentstörungen der Haut bzw. der Neigung dazu, wird diese verzögert bzw. stagniert und die Behandlung wird beschleunigt. 3) Patienten, die empfindlichHaut haben bzw. deren Haut zu Exembildung, Hautentzündung, Juckreiz, Hautflechte, Akne Vulgaris etc neigt, können mit Vitamin E bzw. des o.g.Shiratori Life. Sci. 14, 929 (1974) This enrichment in the skin brings numerous advantages that were surprising and not previously known: 1) Protection of the skin against allergies, in particular sun allergies and protection against UV rays 2) In the case of pigment disorders of the skin or the tendency to do so, this is delayed or stagnated and the treatment is accelerated. 3) Patients who have sensitive skin or whose skin is prone to exeme formation, skin inflammation, itching, skin lichen, acne vulgaris etc. can take vitamin E or the above
Kombination behandelt werden. Combination are treated.
Die Stagnierung der Hautfalten oder Hautstreifen bzw. deren Vorbeugung kann durch Vitamin E und den erfindungsgemäßen Kombinationen erreicht werden.The stagnation of skin folds or strips of skin or their prevention can be achieved by vitamin E and the combinations according to the invention.
Auch bei Patienten, deren Haut zu Wucherung neigt bzw. zur Krebs bildung kann Vitamin E insbesondere seine Kombinationen mit B-Carotin und Canthaxanthin oder deren Derivate verwendet werden.Also in patients whose skin tends to overgrow or to develop cancer Vitamin E in particular can be its combinations with B-carotene and canthaxanthin or their derivatives are used.
Vitamin E in oraler Form muß hoch genug dosiert sein und zwar zwischen 200 bis 500 mg pro Darreichungsform bzw. Kapsel, vorzugsweise zwischen 300 und 500 mg pro Einheit bzw. Kapsel.Vitamin E in oral form must be dosed in high enough doses between 200 to 500 mg per dosage form or capsule, preferably between 300 and 500 mg per unit or capsule.
B-Carotin kann bis maximal 30 mg pro Einheit verwendet werden, während Canthaxanthin zwischen 10 und 50 mg, vorzugsweise zwischen 20 und 40 mg verwendet werden kann.B-carotene can be used up to a maximum of 30 mg per unit while Canthaxanthin used between 10 and 50 mg, preferably between 20 and 40 mg can be.
Man kann auch einen oder mehrere Vitamine der B-Reihe oder Dexapanthenol bzw. CAlcium Pantothenat zusetzen.One can also use one or more B-series vitamins or dexapanthenol or add calcium pantothenate.
Beispiel 1 Kapseln aus: 35 mg Oanthaxanthin 8 mg B-Carotin 8. mg Calcium D Pantothenat 0,15 mg D-Biotin 250 mg Lecithin 400 mg Dl-alpha-Tocopherolacetat 80 mg Sojabohnenöl Beispiel 2 Kapseln aus: 30 mg Canthaxanthin 300 mg DTalpha-Tocopherol-Konzentrat 150 mg Sojabohnenöl Beispiel 3 Kapseln aus: 15 mg B-Carotin 400 mg D-alpha-Tocopherolacetat 120 mg SojabohnenölExample 1 Capsules made from: 35 mg Oanthaxanthin 8 mg B-Carotene 8. mg Calcium D pantothenate 0.15 mg D-biotin 250 mg lecithin 400 mg Dl-alpha-tocopherol acetate 80 mg soybean oil Example 2 capsules made from: 30 mg canthaxanthin 300 mg DTalpha-tocopherol concentrate 150 mg soybean oil Example 3 capsules made from: 15 mg B-carotene 400 mg D-alpha-tocopherol acetate 120 mg soybean oil
Claims (3)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19843410641 DE3410641A1 (en) | 1984-03-23 | 1984-03-23 | Vitamin-containing skin protective composition |
DE8585102222T DE3579343D1 (en) | 1984-03-07 | 1985-02-28 | AGENTS FOR TREATING AND PROTECTING THE SKIN. |
AT85102222T ATE55905T1 (en) | 1984-03-07 | 1985-02-28 | MEANS FOR TREATMENT AND PROTECTION OF THE SKIN. |
DE8989112798T DE3586859D1 (en) | 1984-03-07 | 1985-02-28 | AGENTS FOR TREATING AND PROTECTING THE SKIN. |
EP85102222A EP0158090B1 (en) | 1984-03-07 | 1985-02-28 | Drug for the treatment and the protection of the skin |
CA000475486A CA1257200A (en) | 1984-03-07 | 1985-02-28 | Agents for the treatment and protection of the skin |
AT89112798T ATE82684T1 (en) | 1984-03-07 | 1985-02-28 | MEANS FOR TREATMENT AND PROTECTION OF THE SKIN. |
EP89112798A EP0343694B1 (en) | 1984-03-07 | 1985-02-28 | Agent for the treatmment and protection of the skin |
US07/211,125 US4938960A (en) | 1984-03-07 | 1988-06-21 | Agents for the treatment and protection of the skin |
US07/877,377 US5541220A (en) | 1984-03-07 | 1992-04-29 | Agents for the treatment and protection of the skin |
US08/298,612 US5652261A (en) | 1984-03-07 | 1994-08-31 | Method for the treatment and protection of the skin |
US08/819,097 US5786384A (en) | 1984-03-07 | 1997-03-18 | Agents for the treatment and protection of the skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19843410641 DE3410641A1 (en) | 1984-03-23 | 1984-03-23 | Vitamin-containing skin protective composition |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3410641A1 true DE3410641A1 (en) | 1985-10-24 |
Family
ID=6231354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19843410641 Withdrawn DE3410641A1 (en) | 1984-03-07 | 1984-03-23 | Vitamin-containing skin protective composition |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE3410641A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19605659A1 (en) * | 1996-02-15 | 1997-08-21 | Rainer Dr Zierer | Compositions containing beta-carotene and vitamin=E |
WO2005082360A1 (en) * | 2004-02-27 | 2005-09-09 | Basf Aktiengesellschaft | Peroral preparations containing vitamin e |
-
1984
- 1984-03-23 DE DE19843410641 patent/DE3410641A1/en not_active Withdrawn
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19605659A1 (en) * | 1996-02-15 | 1997-08-21 | Rainer Dr Zierer | Compositions containing beta-carotene and vitamin=E |
DE19605659B4 (en) * | 1996-02-15 | 2011-03-10 | Safetec Gmbh | Use of a combination of beta-carotene and vitamin E derivatives for the treatment of epithelial differentiation disorders |
WO2005082360A1 (en) * | 2004-02-27 | 2005-09-09 | Basf Aktiengesellschaft | Peroral preparations containing vitamin e |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3382616T2 (en) | MEDIATOR OF THE PENETENTIALITY FOR THE TRANSDERMAL ADMINISTRATION OF SYSTEMIC ACTIVE SUBSTANCES. | |
CH659948A5 (en) | AGENTS TO ENHANCE THE ANTITUMOR EFFECTIVENESS OF MITOMYCIN-C AND DOXORUBICIN HYDROCHLORIDE. | |
EP0152106A2 (en) | Antirheumatic compositions | |
DE69634404T2 (en) | CAROTEINOID NICOTINAMIDE ZINC COMPOSITIONS AND METHOD FOR TREATMENT USING THE SAME | |
EP0037488B1 (en) | Pharmaceutical composition for healing inflammatory and/or degenerative and/or atrophic mucous membranes | |
DE3416209A1 (en) | EYE TREATMENT PREPARATIONS | |
EP0198172B1 (en) | Pharmaceutical preparation | |
DE19733892C2 (en) | Anti-irradiation method | |
DE3410641A1 (en) | Vitamin-containing skin protective composition | |
DE1667887C2 (en) | Amino acid solution for parenteral infusion | |
DE60003175T2 (en) | COMBINATION PRODUCT FOR TREATING MALARIA | |
EP1616490A1 (en) | Composition comprising lutein, zinc and copper | |
DE3875637T2 (en) | COMPOSITIONS AND METHODS FOR TREATING STOMACH. | |
DE3901286A1 (en) | Hair tonic with vegetable hypertonics | |
Doss | Die Bildung von Pyridinhämochromogen aus Protohäminmethylester | |
EP0256353A2 (en) | Pharmaceutical therapy against the bad absorption of food or oral drugs | |
DE69214979T2 (en) | New, dietary preparations based on phosphorus-lipid complexes and their use in sleep disorders | |
EP1363512B1 (en) | Beverage | |
DE60020888T2 (en) | EXTRACTS FROM HERBS FOR THE TREATMENT OF COGNITIVE DISTURBANCES DUE TO ESTROGEN LOSS | |
EP0455769B1 (en) | Use of 7-oh-1,2-benzopyrone for the manufacture of a medicament for the treatment of malignant tumours in humans | |
DE3507791A1 (en) | Composition for protecting the skin | |
DE3234366A1 (en) | Pharmaceutical composition, in particular for cancer therapy | |
AT234277B (en) | Process for the manufacture of orally administrable iron preparations | |
DE2015877A1 (en) | drug | |
DE4108951A1 (en) | Immunostimulant for treating tumours, AIDS, leukaemia etc. - comprises extract of Eleuthero=coccus sentiocus, along with animal spleen and thymus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AG | Has addition no. |
Ref country code: DE Ref document number: 3441711 Format of ref document f/p: P |
|
8141 | Disposal/no request for examination |